中文 
English 
| 产品编号 | RC10378 |
| 说明书 | |
| 产品名称 | LSKL, Inhibitor of Thrombospondin (TSP-1) [TGF-β1 Inhibitor ] |
| CAS NO. | 283609-79-0 |
| 分子式 | C21H42N6O5 |
| 分子量 | 458.6 |
| Smiles | CC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O |
| IC50 & Target) | TGF-β1 |
| Sequence | Leu-Ser-Lys-Leu-NH2 |
| 溶解度信息 | DMSO 中的溶解度: 100 mg/mL (218.05 mM; 超声助溶; 吸湿的DMSO 对产品的溶解度有显著影响，请使用新开封的DMSO) H2O 中的溶解度: 50 mg/mL (109.03 mM; 超声助溶) |
| 储存⽅式 | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 产品描述 | LSKL, INhibitor of Thrombospondin (TSP-1) is a TGF-β1 antagonist that inhibits the binding of TSP-1 to LAPand reduces renal interstitial fibrosis and liver fibrosis. LSKL can also inhibit subarachnoid fibrosis, prevent the occurrence of chronic hydrocephalus and improve long-term neurocognitive deficits after subarachnoid hemorrhage by inhibiting TSP-1-mediated TGF-β1 activity. |
| WARNING | THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. This material should be considered hazardous until further information becomes available. Do not ingest,inhale, get in eyes, on skin, or on clothing. Before use, the user must review the complete Safety Data Sheet.Buyer agrees to purchase the material subject to Report’s Terms and Conditions. |
